Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
Clinical trial NCT03968159 · COMPLETED
Trial details
- NCT number
- NCT03968159
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-25
- Primary completion
- 2020-04-30
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.